JCB Laboratories

JCB Laboratories has been at the forefront of shaping industry standards in sterile preparations for nearly two decades, and was one of the first companies in the country to register with the FDA. In December, 2013, as a forward-thinking pharmaceutical supplier, global custom pharmaceutical care leader, Fagron, recognized the opportunity to serve their customers better by acquiring JCB Laboratories. Building off JCBs experience, Fagron developed Fagron Sterile Service (FSS), constructing a state-of-the-art manufacturing facility JCB and FSS, are FDA-registered, 503B Human Drug Outsourcing Facilities that manufacture sterile products. JCB and FSS formulate products with unique qualities specific to customer needs;...

Sterile product compounding,drug shortages,503b outsourcing facility,asc compounding,hospital compounding,anesthesia,dialysis,opthalmology,pain,and urology

Jcb laboratories operates in the Pharmaceutical manufacturing industry.

Jcb laboratories's revenue is 11m - 100m

Jcb laboratories has 11 - 50 employees.